{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:25:34Z","timestamp":1788974734525,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2001,2,1]],"date-time":"2001-02-01T00:00:00Z","timestamp":980985600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2001,2]]},"DOI":"10.1007\/s11894-001-0041-4","type":"journal-article","created":{"date-parts":[[2007,5,19]],"date-time":"2007-05-19T23:02:31Z","timestamp":1179615751000},"page":"54-59","source":"Crossref","is-referenced-by-count":68,"title":["Treatment of Wilson\u2019s disease: What are the relative roles of penicillamine, trientine, and zinc supplementation?"],"prefix":"10.1007","volume":"3","author":[{"given":"Michael L.","family":"Schilsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"41_CR1","first-page":"1091","volume-title":"Diseases of the Liver","author":"ML Schilsky","year":"1999","unstructured":"Schilsky ML, Tavill AS: Wilson\u2019s disease. In Diseases of the Liver. Edited by Schiff ER, Sorrell MF, Maddrey WC. Philadelphia: Lippincott-Raven; 1999:1091\u20131106."},{"key":"41_CR2","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/hep.1840190307","volume":"19","author":"ML Schilsky","year":"1994","unstructured":"Schilsky ML, Scheinberg IH, Sternlieb, I: Liver transplantation for Wilson\u2019s disease: indications and outcome. Hepatology 1994, 19:583\u2013587.","journal-title":"Hepatology"},{"key":"41_CR3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/lt.500050614","volume":"5","author":"B Eghtesad","year":"1999","unstructured":"Eghtesad B, Nezakatgoo N, Geraci LC, et al.: Liver transplantation for Wilson\u2019s disease: a single-center experience. Liver Transplant Surg 1999, 5:467\u2013474. These data concern 45 patients with Wilson\u2019s disease who underwent liver transplantation at the University of Pittsburgh. They confirm results from Schilsky et al. [2], showing survival of approximately 80%, and provide further support for the same recommendations for patient selection for liver transplant with Wilson\u2019s disease, which include fulminant hepatic failure and end-stage liver disease not responsive to medical therapy. In this series, all patients were transplanted for their liver disease. As with the report by Schilsky et al. [2], improvement of the neurologic symptoms in some patients occurred after transplant.","journal-title":"Liver Transplant Surg"},{"key":"41_CR4","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S1357-2725(98)00073-9","volume":"30","author":"K Terada","year":"1998","unstructured":"Terada K, Schilsky ML, Miura N, Sugiyama T: ATP7B (WND) protein. Int J Biochem Cell Biol 1998, 30:1063\u20131067.","journal-title":"Int J Biochem Cell Biol"},{"key":"41_CR5","first-page":"221A","volume":"30","author":"AN Irani","year":"1999","unstructured":"Irani AN, Malhi H, Slehria S, et al.: Complete correction of liver disease following transplantation of normal hepatocytes in LEC rats that model Wilson\u2019s disease [abstract]. Hepatology 1999, 30:221A.","journal-title":"Hepatology"},{"key":"41_CR6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1001\/archneur.1995.00540280019007","volume":"52","author":"IH Scheinberg","year":"1995","unstructured":"Scheinberg IH, Sternlieb I: Treatment of the neurologic manifestations of Wilson\u2019s disease. Arch Neurol 1995, 52:339\u2013340.","journal-title":"Arch Neurol"},{"key":"41_CR7","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/archneur.1995.00540280019008","volume":"52","author":"GJ Brewer","year":"1995","unstructured":"Brewer GJ: Commentary on Scheinberg and Sternlieb. Arch Neurol 1995, 52:340.","journal-title":"Arch Neurol"},{"key":"41_CR8","first-page":"126","volume-title":"Major Problems in Internal Medicine","author":"IH Scheinberg","year":"1984","unstructured":"Scheinberg, IH, Sternlieb I: Wilson\u2019s Disease. In Major Problems in Internal Medicine, vol 23. Philadelphia: WB Saunders; 1984:126\u2013155."},{"key":"41_CR9","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1056\/NEJM196802152780702","volume":"278","author":"I Sternlieb","year":"1968","unstructured":"Sternlieb I, Scheinberg IH: Prevention of Wilson\u2019s disease in asymptomatic patients: prophylaxis of Wilson\u2019s disease. N Engl J Med 1968, 278:352\u2013355.","journal-title":"N Engl J Med"},{"key":"41_CR10","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/archneur.1987.00520170020016","volume":"44","author":"GJ Brewer","year":"1987","unstructured":"Brewer GJ, Terry CA, Aisen AM, Hall GM: Worsening of neurologic syndrome in patients with Wilson\u2019s disease with metal penicillamine therapy. Arch Neurol 1987, 44:490\u2013493.","journal-title":"Arch Neurol"},{"key":"41_CR11","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/00005176-199911000-00031","volume":"29","author":"J Deutscher","year":"1999","unstructured":"Deutscher J, Kiess W, Scheerschmidt G, Willgerodt H: Potential hepatotoxicity of penicillamine treatment in three patients with Wilson\u2019s disease. J Pediatr Gastroenterol Nutr 1999, 29:628.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"41_CR12","volume-title":"Orphan Diseases and Orphan Drugs","author":"IH Scheinberg","year":"1985","unstructured":"Scheinberg IH, Walshe JM: Orphan Diseases and Orphan Drugs. London: Manchester University Press; 1985."},{"key":"41_CR13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM198707233170405","volume":"317","author":"IH Scheinberg","year":"1987","unstructured":"Scheinberg IH, Jaffe ME, Sternlieb I: The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilson\u2019s disease. N Engl J Med 1987, 317:209\u2013213.","journal-title":"N Engl J Med"},{"key":"41_CR14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0022-3476(96)70412-2","volume":"128","author":"EE Santos-Silva","year":"1996","unstructured":"Santos-Silva EE, Sarles J, Buts JP, Sokol EM: Successful medical treatment of severely decompensated Wilson disease. J Pediatrics 1996, 128:285\u2013287.","journal-title":"J Pediatrics"},{"key":"41_CR15","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0022-2143(98)90039-7","volume":"132","author":"GJ Brewer","year":"1998","unstructured":"Brewer GJ, Dick RD, Johnson VD, et al.: Treatment of Wilson\u2019s disease with zinc: XV. Long-term follow-up studies. J Lab Clin Med 1998, 132:264\u2013278. Results of a long-term study of 141 patients with Wilson\u2019s disease successfully treated with zinc salts. This report shows the efficacy of zinc for maintenance therapy and its minimal toxicity.","journal-title":"J Lab Clin Med"},{"key":"41_CR16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0377-8401(77)90027-X","volume":"2","author":"NF Suttle","year":"1977","unstructured":"Suttle NF: Reducing the potential copper toxicity of concentrates to sheep by the use of molybdenum and sulphur supplements. Anim Feed Sci Technol 1977, 2:235\u2013246.","journal-title":"Anim Feed Sci Technol"},{"key":"41_CR17","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/archneur.1996.00550100103019","volume":"53","author":"GJ Brewer","year":"1996","unstructured":"Brewer GJ, Johnson V, Dick RD, et al.: Treatment of Wilson disease with ammonium tetrathiomolybdate. II. Initial therapy in 33 neurologically affected patients and follow-up with zinc therapy. Arch Neurol 1996, 53:1017\u20131025.","journal-title":"Arch Neurol"},{"key":"41_CR18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1445-5994.1998.tb02975.x","volume":"28","author":"H Karunajeewa","year":"1998","unstructured":"Karunajeewa H, Wall A, Metz J, Grigg A: Cytopenias secondary to copper depletion complicating ammonium tetrathiomolybdate therapy for Wilson\u2019s disease. Aust NZ J Med, 1998, 28:215\u2013216.","journal-title":"Aust NZ J Med"},{"key":"41_CR19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF02779512","volume":"26","author":"N Shimono","year":"1991","unstructured":"Shimono N, Ishihashi H, Ikematsu H, et al.: Fulminant hepatic failure during perinatal period in a pregnant woman with Wilson\u2019s disease. Gastroenterol Jpn 1991, 26:69\u201373.","journal-title":"Gastroenterol Jpn"},{"key":"41_CR20","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/hep.510310239","volume":"31","author":"I Sternlieb","year":"2000","unstructured":"Sternlieb I. Wilson\u2019s disease and pregnancy. Hepatology 2000, 31:531\u2013532. Commentary on Brewer et al. [21] and review of the experience with penicillamine and trientine for pregnancy in Wilson\u2019s disease.","journal-title":"Hepatology"},{"key":"41_CR21","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/hep.510310216","volume":"31","author":"GJ Brewer","year":"2000","unstructured":"Brewer GJ, Johnson VD, Dick RD, et al.: Treatment of Wilson\u2019s disease with zinc. XVII. Treatment during pregnancy. Hepaology 2000, 31:364\u2013370. Review of the experience with zinc treatment for 26 pregnancies in 19 patients with Wilson\u2019s disease. One birth defect and one episode of microcephaly occurred. All mothers were safely treated with zinc. The study is limited by its small number of patients, making it difficult to know if there are statistical differences in the outcome of pregnancies compared with unaffected individuals or those treated with penicillamine or trientine.","journal-title":"Hepaology"},{"key":"41_CR22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0022-510X(87)90116-X","volume":"77","author":"TU Hoogenrad","year":"1987","unstructured":"Hoogenrad TU, Van Hattum J, Vanden Hamer CJ: Management of Wilson\u2019s disease with zinc sulfate: experience in a series of 27 patients. J Neurol Sci 1987, 77:137\u2013146.","journal-title":"J Neurol Sci"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-001-0041-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-001-0041-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-001-0041-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:03:40Z","timestamp":1559433820000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-001-0041-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,2]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,2]]}},"alternative-id":["41"],"URL":"https:\/\/doi.org\/10.1007\/s11894-001-0041-4","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,2]]}}}